Procter & Gamble Health Ltd Share Price

Pharmaceuticals

NSE: PGHL Small Cap ISIN: INE199A01012

As on 19 November 2025 at 01:30 IST

₹5,877

-38.50

(-0.65%)

Sell Buy

Over 1 Month

-5.26%

Over 6 Months

12.67%

Over 1 Year

15.61%

Over 3 Years

39.50%

Procter & Gamble Health Ltd Summary

Close ₹5,915.50

Open ₹5,850

High ₹5,948

Low ₹5,850

Volume 11,071

Net Turnover (in Cr) ₹6.55

52Wk High ₹6,739

52Wk Low ₹4,903.85

52Wk High / Low

4,903.85

6,739

Procter & Gamble Health Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹9,819.36

EPS (TTM) 184.83

Book Value (BV) 373.34

Div. Yield 2.12 %

P/E (TTM) 31.95

Price/Book Value 15.82

Delivery % 69.46 %

Face Value 10

Key Ratios

PE Ratio 48.55

PB Ratio 15.90

EV to Sales 8.94

PEG Ratio -

ROA 40.30

ROE 32.74

Debt-Equity 0.01

Net Profit Margin 25.09

Operating Profit Margin 35.19

Procter & Gamble Health Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	944.52	1,166.89	1,248.01	1,127.60	1,026.83
Total Expenses	632.90	873.38	933.81	874.23	793.55
Profit Before Tax	311.62	273.32	314.20	253.37	233.28
Profit After Tax	234.41	200.98	229.47	192.52	176.80
Operating Profit After Depreciation	312.05	294.23	314.97	253.79	234.08

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	111.74	126.60	141.72	109.06	100.96
Total Non Current Assets	267.81	270.14	305.09	280.08	259.02
Total Current Assets	526.39	524.22	796.10	608.04	727.14
Total Assets	794.20	794.36	1,101.19	888.12	986.16
Total Shareholder's Fund	536.96	538.24	750.89	616.49	703.71

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	168.69	228.29	236.01	169.52	247.26
Net Cash Used In Investing Activities	9.59	-6.87	-21.50	-25.54	-32.27
Net Cash Used In Financing Activities	-234.74	-418.11	-98.49	-288.63	-386.63

No data available

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	324.92	338.74	310.99	309.77	313.41
Total Expenses	204.65	248.40	230.07	186.34	199.37
Profit Before Tax	119.02	88.81	78.53	121.69	111.40
Profit After Tax	88.54	66.18	61.18	90.90	82.33
Operating Profit after Depreciation	125.22	94.37	84.03	127.39	117.32

Procter & Gamble Health Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 5,861

S2 5,806.50

S3 5,763

Pivot 5,904.50

R1 5,959

R2 6,002.50

R3 6,057

Moving Average

20 SMA 6,053.43

50 SMA 6,196.70

100 SMA 6,121.23

200 SMA 5,732.52

Procter & Gamble Health Ltd Corporate Actions

Procter & Gamble Health Ltd

₹45.0/Share

Announcement Date 22 Aug 2025

Record Date 22 Aug 2025

Div Yield 450%

AGM Date: 26 Nov 2020

AGM 26/11/2020 We would like to inform you that the 53rd Annual General Meeting of the Company was held on November 26, 2020 at 3.30 p.m. through Video Conference / Other Audio Visual Means. In this respect, please find enclosed a summary of proceedings of the 53rd Annual General Meeting. (As per BSE Announcement Dated on 27/11/2020) We would like to inform you that the 53rd Annual General Meeting of the Company was held on November 26, 2020 at 3.30 p.m. through Video Conference / Other Audio Visual Means. In this respect, please find enclosed below: 1. Voting results in respect of the business conducted at the Annual General Meeting, as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 2. Scrutinizer's Report Kindly take the above on record and oblige. (As Per BSE Announcement Dated on 11/28/2020 1:14:05 PM) Procter & Gamble Health Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 28/11/2020)

AGM Date: 11 Nov 2021

We would like to inform you that the Register of Members and Share Transfer books shall remain closed from Friday November 05 2021 to Thursday November 11 2021 (both days inclusive) for the purposes of Annual General Meeting and payment of dividend for the year ended June 30 2021 if approved by members at the 54th Annual General Meeting. Kindly take the same on record and oblige. We would like to inform you that the 54th Annual General Meeting of the Company was held on November 11 2021 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect please find enclosed below: 1. Voting results in respect of the business conducted at the Annual General Meeting as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015; and 2. Scrutinizers Report Kindly take the above on record and oblige. Procter & Gamble Health Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 11/12/2021 8:32:20 AM)

AGM Date: 23 Nov 2022

AGM 23/11/2022 We refer to our letter dated September 8, 2022, intimating the date of 55th Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2022 and Notice calling the 55th Annual General Meeting of the Company. In accordance with, the General Circular No. 02/2022 issued by MCA and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2022/62, the Annual Report for the Financial Year 2021-22, including the Notice of AGM has been sent in electronic mode to Members today, October 31,2022, whose e-mail addresses are registered with the Company. The copy of the Notice along with the Annual Report is enclosed herewith and is also available on the Company's website: https://www.pghealthindia.com/investors/. Kindly take the same on record and oblige. We refer to our letter dated September 8, 2022, intimating the date of 55th Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2022 and Notice calling the 55th Annual General Meeting of the Company. In accordance with, the General Circular No. 02/2022 issued by MCA and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2022/62, the Annual Report for the Financial Year 2021-22, including the Notice of AGM has been sent in electronic mode to Members today, October 31,2022, whose e-mail addresses are registered with the Company. The copy of the Notice along with the Annual Report is enclosed herewith and is also available on the Company's website: https://www.pghealthindia.com/investors/. Kindly take the same on record and oblige. We refer to our letter dated September 8, 2022, intimating the date of 55th Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2022 and Notice calling the 55th Annual General Meeting of the Company. In accordance with, the General Circular No. 02/2022 issued by MCA and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2022/62, the Annual Report for the Financial Year 2021-22, including the Notice of AGM has been sent in electronic mode to Members today, October 31,2022, whose e-mail addresses are registered with the Company. The copy of the Notice along with the Annual Report is enclosed herewith and is also available on the Company's website: https://www.pghealthindia.com/investors/. Kindly take the same on record and oblige. (As Per BSE Announcement Dated on 31.10.2022) We would like to inform you that the 55th Annual General Meeting of the Company was held today, November 23, 2022 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect, please find enclosed a summary of proceedings of the 55th Annual General Meeting. Further, we have enclosed copy of presentation on business review and overview on Corporate Social Responsibility activities of the Company presented at the 55th Annual General Meeting held today, i.e., November 23, 2022. (As per BSE Announcement Dated on 23/11/2022) We would like to inform you that the 55th Annual General Meeting of the Company was held on November 23, 2022 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect, please find enclosed below: 1. Voting results in respect of the business conducted at the Annual General Meeting, as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 2. Scrutinizer's Report Kindly take the above on record and oblige. We are pleased to informed that the Shareholders of the Company have at their Annual General Meeting held on November 23, 2022, approved re-appointment of M/s. Haribhakti & Co. LLP, Chartered Accountants, as the Statutory Auditors for a second term of 5 (five) years ie. to hold office from the conclusion of this 55th Annual General Meeting upto the conclusion of 60th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 24/11/2022)

AGM Date: 30 Nov 2023

AGM 21/11/2023 We would like to inform you that the 56th Annual General Meeting( AGM) of the Company is to be held on Thursday, November 30,2023. The register of members and share transfer books shall remain closed from Friday, November 24,2023 to Thursday, November 30,2023 for the purpose of the AGM and payment of dividend for the year ended June 30,2023. (As per BSE Announcement Dated on 20/10/2023) AGM 30/11/2023 (Revised) (As Per BSE Bulletin Dated on 25.10.2023) We would like to inform you that the 56th Annual General Meeting of the Company was held on November 30,2023 at 3:30 p.m. through video conference/ other audio visual means. Find enclosed a copy of presentation on business review of the Company as presented at the 56th Annual General Meeting. We would like to inform you that the 56th Annual General Meeting was held on November 30,2023 at 3:33 p.m. In this respect find enclosed the voting result and scrutinizers report. Find enclosed the scrutinizers'' report on the voting and remote evoting with respect to the 56th AGM held on November 30,2023. (As per BSE Announcement Dated on 01/12/2023)

AGM Date: 05 Dec 2024

We would like to inform that the Register of Members and Share transfer books shall remain closed from November 29, 2024 to December 5, 2024 for the purpose of Annual General Meeting and payment of dividend for the Financial Year 2023-24, if approved by the shareholders of the Company at their 57th Annual General Meeting to be held on December 5, 2024. The notice of the Annual General Meeting will be shared in the due course. Dear Sir, Please find the proceedings of the 57th Annual General meeting held on December 5, 2024. (As per BSE Announcement Dated on 05/12/2024)

AGM Date: 29 Aug 2025

AGM 29/08/2025 Dear Sir, Please find enclosed the Annual Report for the Financial Year 2024-25 and notice calling 58th Annual General Meeting of the Company (As per BSE Announcement Dated on 06.08.2025) Dear Sir, Please find attached voting results for the resolutions proposed to be passed at the Annual General meeting held today, along with scrutinizers report thereon. Please find attached proceedings of the annual general meeting held for financial year 2024-25 (As Per BSE Announcement Dated on:29.08.2025)

Procter & Gamble Health Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Procter & Gamble Health Ltd Top Mutal Funds Invested

Fund Name	AUM
UTI-MNC Fund	5.11%
UTI-Healthcare Fund	3.67%
DSP Healthcare Fund	3.12%
ICICI Pru Smallcap Fund	2.55%
Aditya Birla SL Pharma & Healthcare Fund	1.38%

Procter & Gamble Health Ltd News

Procter & Gamble Health to hold board meeting

On 5 November 2025

30 Sep 2025, 10:18 am

Procter & Gamble Health announces change in HR leadership

16 Sep 2025, 07:02 pm

Procter & Gamble Health to convene AGM

On 29 August 2025

07 Aug 2025, 03:42 pm

P&G Health spurts after PAT climbs over threefold to Rs 66 cr in Q1 FY26

Procter & Gamble Health surged 7.66% to Rs 6,351.50 after the company's standalone net profit soared 294.4% to Rs 66.18 crore in Q1 FY26 compared with Rs 16.78 crore in Q1 FY25.

01 Aug 2025, 03:04 pm

Procter & Gamble Health Ltd Falls 2.2%

Procter & Gamble Health Ltd has lost 3.24% over last one month compared to 0.71% gain in BSE Healthcare index and 1.75% rise in the SENSEX

14 Jul 2025, 09:30 am

Procter & Gamble Health Ltd Stock Analysis

Annual revenue for Procter & Gamble Health Ltd decreased by 19.06% to ₹944.52 crore in FY 2025 from ₹1,166.89 crore in FY 2024.
Annual Net Profit for Procter & Gamble Health Ltd increased by 16.63% to ₹234.41 crore in FY 2025 from ₹200.98 crore in FY 2024.
Promoter Shareholding in Procter & Gamble Health Ltd remains unchanged by 0.00% in the most recent quarter, from 51.82% in June 2025 to 51.82% in September 2025.
Procter & Gamble Health Ltd delivered a 1-year return of 15.61% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Procter & Gamble Health Ltd share price moved down by 0.65% from its previous close of INR ₹5,915.50. The latest Procter & Gamble Health Ltd share price is INR ₹5,877.
Procter & Gamble Health Ltd share price today has been at a low of 5,867.50 and a high of 5,919.50. Over the past 52 weeks, the Procter & Gamble Health Ltd share price has seen a low of 4,903.85 and a high of 6,739.